Ignite Creation Date:
2024-05-06 @ 3:55 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04801446
Status:
COMPLETED
Last Update Posted:
2023-09-22
First Post:
2021-01-05
Brief Title:
Transcranial Direct Current Stimulation in Acute Ischemic Stroke Treatment
Sponsor:
General University Hospital Prague
Organization:
General University Hospital Prague
Study Overview
Official Title:
Transcranial Direct Current Stimulation in Acute Ischemic Stroke Treatment - Safety and Feasibility Trial
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DICAST-SF
Brief Summary:
This prospective interventional single center randomized sham controlled dose-escalation study will assess safety tolerability feasibility and potential efficacy of transcranial direct current stimulation tDCS in acute stroke patients with substantial salvageable penumbra due to a large vessel occlusion who are ineligible for endovascular therapy EVT Patients will be randomized in a 31 design to cathodal versus sham control tDCS at each six designed dose tiers The dose tiers will be increasing in both intensity and duration of the stimulation The occurrence of symptomatic intracranial hemorrhage will determine the pace of the escalation through the dose tiers
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None